{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T04:09:53Z","timestamp":1789186193367,"version":"build-2803163510"},"reference-count":19,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Contemporary Clinical Trials"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.cct.2026.108420","type":"journal-article","created":{"date-parts":[[2026,8,2]],"date-time":"2026-08-02T19:06:17Z","timestamp":1785697577000},"page":"108420","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["A two-stage design for evaluating induction and maintenance therapies for a time to event endpoint"],"prefix":"10.1016","volume":"169","author":[{"given":"Hui","family":"Quan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhixing","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rick","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Somnath","family":"Sarkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunfu","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cct.2026.108420_bb0005","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1001\/jama.2021.3224","article-title":"Effect of continued weekly subcutaneous semaglutide vs placebo on weight loss maintenance in adults with overweight or obesity The STEP 4 randomized clinical trial","volume":"325","author":"Rubino","year":"2021","journal-title":"JAMA"},{"key":"10.1016\/j.cct.2026.108420_bb0010","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0140-6736(97)11509-4","article-title":"Randomized placebo-controlled trial of orlistat for weight loss and prevention of weight regain in obese patients","volume":"352","author":"Sjostrom","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.cct.2026.108420_bb0015","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1016\/S0140-6736(89)91499-2","article-title":"International trial of long-term dexfenfluramine in obesity","volume":"2","author":"Guy-Grand","year":"1989","journal-title":"Lancet"},{"key":"10.1016\/j.cct.2026.108420_bb0020","series-title":"Draft Guidance: Crohn\u2019s Disease: Developinig Drugs for Treatment, Guidance for Industry","author":"FDA","year":"2022"},{"key":"10.1016\/j.cct.2026.108420_bb0025","series-title":"Draft Guidance: Ulcerative Colitis: Developinig Drugs for Treatment, Guidance for Industry","author":"FDA","year":"2022"},{"key":"10.1016\/j.cct.2026.108420_bb0030","doi-asserted-by":"crossref","DOI":"10.1002\/sim.70382","article-title":"Sequential parallel comparison design for assessing induction, maintenance and other treatment effects on a binary endpoint","volume":"45","author":"Quan","year":"2026","journal-title":"Stat. Med."},{"key":"10.1016\/j.cct.2026.108420_bb0035","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1111\/j.0006-341X.2002.00048.x","article-title":"Estimation of survival distributions of treatment policies in two-stage randomization designs in clinical trials","volume":"58","author":"Lunceford","year":"2002","journal-title":"Biometrics"},{"key":"10.1016\/j.cct.2026.108420_bb0040","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1111\/j.1541-0420.2007.00707.x","article-title":"Cox regression methods for two-stage randomization designs","volume":"63","author":"Lokhnygina","year":"2007","journal-title":"Biometrics"},{"key":"10.1016\/j.cct.2026.108420_bb0045","doi-asserted-by":"crossref","first-page":"4161","DOI":"10.1002\/sim.3309","article-title":"Two-stage randomization designs in drug development","volume":"27","author":"Wolbers","year":"2008","journal-title":"Stat. Med."},{"key":"10.1016\/j.cct.2026.108420_bb0050","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1080\/01621459.1996.10476908","article-title":"Multiple imputation after 18+ years","volume":"91","author":"Rubin","year":"1996","journal-title":"J. Am. Stat. Assoc."},{"key":"10.1016\/j.cct.2026.108420_bb0055","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/S2215-0366(14)00092-3","article-title":"Placebo effects in psychiatry: mediators and moderators","volume":"2","author":"Weimer","year":"2015","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.cct.2026.108420_bb0060","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S1474-4422(02)00038-8","article-title":"The placebo effect in neurological disorders","volume":"1","author":"de la Fuente-Fernandez","year":"2002","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.cct.2026.108420_bb0065","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1159\/000069738","article-title":"The problem of placebo response in clinical trials for psychiatric disorders: culprits, possible remedies, and a novel study design approach","volume":"72","author":"Fava","year":"2003","journal-title":"Psychother. Psychosom."},{"key":"10.1016\/j.cct.2026.108420_bb0070","doi-asserted-by":"crossref","first-page":"3496","DOI":"10.1002\/sim.4412","article-title":"Estimation of treatment effect for the sequential parallel design","volume":"30","author":"Tamura1","year":"2011","journal-title":"Stat. Med."},{"key":"10.1016\/j.cct.2026.108420_bb0075","doi-asserted-by":"crossref","first-page":"2793","DOI":"10.1002\/sim.4292","article-title":"Optimality, sample size, and power calculations for the sequential parallel comparison design","volume":"30","author":"Ivanova","year":"2011","journal-title":"Stat. Med."},{"key":"10.1016\/j.cct.2026.108420_bb0080","doi-asserted-by":"crossref","first-page":"2725","DOI":"10.1002\/sim.9381","article-title":"A generalized weighted combination test of treatment effect for clinical trials with a sequential parallel comparison design and binary endpoint","volume":"41","author":"Quan","year":"2022","journal-title":"Stat. Med."},{"key":"10.1016\/j.cct.2026.108420_bb0085","doi-asserted-by":"crossref","first-page":"4112","DOI":"10.1002\/sim.8288","article-title":"Comparison of novel methods in two-way enriched clinical trial design","volume":"38","author":"Liu","year":"2019","journal-title":"Stat. Med."},{"key":"10.1016\/j.cct.2026.108420_bb0090","doi-asserted-by":"crossref","first-page":"2767","DOI":"10.1002\/sim.5728","article-title":"A repeated measures model for analysis of continuous outcomes in sequential parallel comparison design studies","volume":"32","author":"Doros","year":"2013","journal-title":"Stat. Med."},{"key":"10.1016\/j.cct.2026.108420_bb0095","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/j.cct.2011.04.006","article-title":"Evaluation of performance of some enrichment designs dealing with high placebo response in psychiatric clinical trials","volume":"32","author":"Chen","year":"2011","journal-title":"Contemp. Clin. Trials"}],"container-title":["Contemporary Clinical Trials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1551714426002065?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1551714426002065?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T03:38:32Z","timestamp":1789184312000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1551714426002065"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":19,"alternative-id":["S1551714426002065"],"URL":"https:\/\/doi.org\/10.1016\/j.cct.2026.108420","relation":{},"ISSN":["1551-7144"],"issn-type":[{"value":"1551-7144","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A two-stage design for evaluating induction and maintenance therapies for a time to event endpoint","name":"articletitle","label":"Article Title"},{"value":"Contemporary Clinical Trials","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cct.2026.108420","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"108420"}}